• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素注射前痉挛性发声障碍患者的肌电图评估

Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.

作者信息

Rodriquez A A, Ford C N, Bless D M, Harmon R L

机构信息

University of Wisconsin-Madison Medical School 53792-3256.

出版信息

Electromyogr Clin Neurophysiol. 1994 Oct-Nov;34(7):403-7.

PMID:7859668
Abstract

Electromyographic (EMG) evidence of inappropriate muscle activity (IMA) in the cricothyroid (CT) and vocalis (V) (thyroarytenoid) muscles was correlated with clinical voice measures in 32 patients with spasmodic dysphonia (SD). Subjective voice rating and quantified fluency and laryngeal diadochokinesis measures were obtained prior to botulinum toxin (Botox) injection into the V muscles. Pre-Botox EMG was performed using a monopolar needle electrode. Each muscle was sequentially examined at rest, during vocal click, scale, sustained "E" at different pitches, and repeated "E" voicings for brief periods. A three point EMG severity scale was used to grade the amount of IMA seen in each muscle. EMG evaluation showed no evidence of lower motor neuron involvement but did reveal IMA in 81.3% of the subjects. There were no significant correlations for the patients between different EMG-based IMA severity scales and the measures of voice quality and sound production. EMG did discriminate between predominantly adductor and abductor SD pattern types, but could not correctly differentiate a mixed SD group. Those patients with adductor SD displayed IMA in the V and CT muscles, while those with abductor SD displayed more IMA in the CT than the V muscles. Sequential EMG assessment of CT and V IMA in SD did not predict clinical severity or outcome following Botox injection into the V muscles.

摘要

在32例痉挛性发声障碍(SD)患者中,环甲肌(CT)和声肌(V,即甲杓肌)不适当肌肉活动(IMA)的肌电图(EMG)证据与临床嗓音指标相关。在向V肌注射肉毒杆菌毒素(肉毒素)之前,获取主观嗓音评分、量化的流畅度和喉快速交替运动测量值。注射肉毒素前的EMG检查使用单极针电极。依次在静息状态、发声时发出咔哒声、唱音阶、不同音高持续发“E”音以及短时间重复发“E”音时检查每块肌肉。使用三点EMG严重程度量表对每块肌肉中观察到的IMA量进行分级。EMG评估未显示下运动神经元受累的证据,但确实在81.3%的受试者中发现了IMA。不同基于EMG的IMA严重程度量表与嗓音质量和发声测量值之间,患者并无显著相关性。EMG确实能区分主要为内收型和外展型的SD模式类型,但无法正确区分混合型SD组。内收型SD患者在V肌和CT肌中显示IMA,而外展型SD患者在CT肌中显示的IMA比V肌更多。对SD患者的CT肌和V肌IMA进行连续EMG评估,并不能预测向V肌注射肉毒素后的临床严重程度或结果。

相似文献

1
Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.肉毒杆菌毒素注射前痉挛性发声障碍患者的肌电图评估
Electromyogr Clin Neurophysiol. 1994 Oct-Nov;34(7):403-7.
2
Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.肉毒杆菌毒素注射治疗痉挛性发声障碍患者主观反应的前瞻性研究。
J Otolaryngol. 1996 Apr;25(2):66-74.
3
Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.肉毒杆菌毒素注射治疗痉挛性发声障碍:诗里拉医院的经验
J Med Assoc Thai. 2006 Dec;89(12):2077-80.
4
[Treatment of spasmodic dysphonia with botulinum toxin].[肉毒杆菌毒素治疗痉挛性发声障碍]
Ann Otolaryngol Chir Cervicofac. 1991;108(8):477-82; discussion 482-3.
5
Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.神经肌肉活动对痉挛性发音障碍中肉毒杆菌毒素注射反应的影响。
J Otolaryngol. 1995 Aug;24(4):209-16.
6
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).喉内收肌肌张力障碍(痉挛性发声障碍):肉毒杆菌毒素(保妥适)局部注射治疗。
Mov Disord. 1989;4(4):287-96. doi: 10.1002/mds.870040401.
7
[Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].[肉毒杆菌毒素。痉挛性发声障碍(喉外展肌肌张力障碍)的一种新的治疗选择]
Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):841-3.
8
Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.肉毒杆菌毒素注射治疗内收型痉挛性发声障碍的方法比较
J Otolaryngol. 1995 Dec;24(6):345-51.
9
[Indications for botulinum toxin in laryngectomy].[喉切除术中肉毒杆菌毒素的适应证]
Rev Laryngol Otol Rhinol (Bord). 1993;114(4):281-7.
10
Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.肉毒杆菌毒素治疗内收型痉挛性发音障碍的双盲对照研究。
Laryngoscope. 1991 Jun;101(6 Pt 1):630-4. doi: 10.1288/00005537-199106000-00010.

引用本文的文献

1
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.肉毒毒素神经毒素疗法在喉部肌张力障碍的临床治疗中的应用。
Toxins (Basel). 2022 Dec 1;14(12):844. doi: 10.3390/toxins14120844.
2
Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia.内收型痉挛性发声障碍患者行内镜下甲杓肌神经切除术的发声效果
Eur Arch Otorhinolaryngol. 2014 Dec;271(12):3249-54. doi: 10.1007/s00405-014-3129-9. Epub 2014 Jun 12.
3
Spasmodic dysphonia: a laryngeal control disorder specific to speech.
痉挛性发声障碍:一种特定于言语的喉部控制障碍。
J Neurosci. 2011 Jan 19;31(3):793-7. doi: 10.1523/JNEUROSCI.2758-10.2011.
4
Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.来自高质量研究设计的关于肉毒杆菌毒素治疗痉挛性发音障碍有效性的证据。
J Neural Transm (Vienna). 2008;115(4):625-30. doi: 10.1007/s00702-007-0757-x. Epub 2007 Jun 14.
5
Botulinum toxin injections for the treatment of spasmodic dysphonia.肉毒杆菌毒素注射治疗痉挛性发声障碍。
Cochrane Database Syst Rev. 2004;2004(3):CD004327. doi: 10.1002/14651858.CD004327.pub2.